CLINICAL_TRIALS
trial_result
· 2023-07-28
Clinical Trial Update: Role of Curcumin in Paclitaxel Induced PN [Phase 2]
Summary
Phase 2 clinical trial exploring curcumin for prevention or treatment of paclitaxel-induced peripheral neuropathy in chemotherapy patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ain Shams University | Conditions: Chemotherapy-induced Peripheral Neuropathy | Phase 2 | Status: UNKNOWN